|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
EP1382969A1
(en)
|
2002-07-17 |
2004-01-21 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Diagnosis and prevention of cancer cell invasion
|
|
JP2009507080A
(en)
|
2005-09-07 |
2009-02-19 |
リゲル ファーマシューティカルズ，インコーポレーテッド |
Triazole derivatives useful as Axl inhibitors
|
|
JP5129143B2
(en)
|
2005-10-07 |
2013-01-23 |
エグゼリクシス， インコーポレイテッド |
MEK inhibitor and method of use thereof
|
|
US8097630B2
(en)
|
2006-10-10 |
2012-01-17 |
Rigel Pharmaceuticals, Inc. |
Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors
|
|
JP2008130120A
(en)
|
2006-11-17 |
2008-06-05 |
Sharp Corp |
Optical pickup device
|
|
WO2008080134A2
(en)
|
2006-12-22 |
2008-07-03 |
Rigel Pharmaceuticals, Inc. |
4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors
|
|
US7709482B2
(en)
|
2006-12-29 |
2010-05-04 |
Rigel Pharmaceuticals, Inc. |
Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
|
|
ES2656496T3
(en)
|
2006-12-29 |
2018-02-27 |
Rigel Pharmaceuticals, Inc. |
Substituted triazoles useful as AXL inhibitors
|
|
WO2008083353A1
(en)
|
2006-12-29 |
2008-07-10 |
Rigel Pharmaceuticals, Inc. |
Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
|
|
EP2114955B1
(en)
|
2006-12-29 |
2013-02-13 |
Rigel Pharmaceuticals, Inc. |
Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
|
|
CA2710046C
(en)
|
2006-12-29 |
2016-02-09 |
Rigel Pharmaceuticals, Inc. |
N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
|
|
EP2205592B1
(en)
|
2007-10-26 |
2013-05-08 |
Rigel Pharmaceuticals, Inc. |
Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
|
|
SG10201405835TA
(en)
|
2007-11-12 |
2014-10-30 |
U3 Pharma Gmbh |
Axl antibodies
|
|
AU2008321835B2
(en)
|
2007-11-15 |
2014-11-20 |
Chugai Seiyaku Kabushiki Kaisha |
Monoclonal antibody capable of binding to anexelekto, and use thereof
|
|
PT2387395E
(en)
|
2009-01-16 |
2015-02-04 |
Rigel Pharmaceuticals Inc |
Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
|
|
AU2010247464B2
(en)
|
2009-05-11 |
2014-09-11 |
U3 Pharma Gmbh |
Humanized AXL antibodies
|
|
BRPI1011145A2
(en)
|
2009-05-15 |
2016-03-15 |
Chugai Pharmaceutical Co Ltd |
anti-axl antibody
|
|
AR082017A1
(en)
|
2010-06-18 |
2012-11-07 |
Genentech Inc |
ANTI-AXL ANTIBODIES (THYROSINE KINASE RECEPTOR) AND METHODS OF USE
|
|
US9249228B2
(en)
|
2011-06-22 |
2016-02-02 |
Oribase Pharma |
Anti-Axl antibodies and uses thereof
|
|
US9409988B2
(en)
|
2011-06-22 |
2016-08-09 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Anti-Axl antibodies and uses thereof
|
|
EP2589609A1
(en)
|
2011-11-03 |
2013-05-08 |
Pierre Fabre Medicament |
Antigen binding protein and its use as addressing product for the treatment of cancer
|
|
TWI609887B
(en)
|
2012-11-05 |
2018-01-01 |
皮爾法伯製藥公司 |
Novel antigen binding proteins and their use as addressing product for the treatment of cancer
|
|
GB201410826D0
(en)
|
2014-06-18 |
2014-07-30 |
Bergenbio As |
Anti-axl antibodies
|
|
GB201410825D0
(en)
|
2014-06-18 |
2014-07-30 |
Bergenbio As |
Anti-axl antibodies
|
|
WO2016097370A2
(en)
|
2014-12-18 |
2016-06-23 |
Bergen Teknologioverføring As |
Anti-axl antagonistic antibodies
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
GB201509338D0
(en)
|
2015-05-29 |
2015-07-15 |
Bergenbio As |
Combination therapy
|
|
GB201610902D0
(en)
|
2016-06-22 |
2016-08-03 |
Bergen Teknologioverforing As And Bergenbio As |
Anti-Axl Antagonistic Antibodies
|
|
CN109562282A
(en)
*
|
2016-07-29 |
2019-04-02 |
伊莱利利公司 |
MERESTINIB and anti-PD-L1 or the combination treatment of anti-PD-1 inhibitor are used for treating cancer
|